Om episode
Late Friday, two conflicting rulings threw a key abortion medication’s FDA approval into question. Today on Post Reports, we break down the legal confusion and talk about what could happen next. At the center of this unprecedented legal clash is mifepristone, a drug that is part of a two-step abortion pill regimen used by millions of people. A federal judge in Texas blocked the FDA’s longtime approval of the drug. Less than an hour later, another federal judge, in Washington state, ordered that the drug remain available in a swath of states. The dueling cases are creating confusion and questions about the future of medication abortion in America. Today on “Post Reports,” legal affairs reporter Ann Marimow walks through the cases and what they mean. Read more: A Texas abortion pill ruling threatens the FDA.Can I still get a medication abortion?In a divided nation, dueling decisions on an abortion pill. Don’t miss a chance to experience “Post Reports” live! “Post Reports” senior host Martine Powers will be in conversation with author Curtis Sittenfeld at Sixth & I in Washington at 7 p.m. on April 13. Get tickets here.
Nyeste episoder
Deep Reads: Public memories. Private struggles.
The election that could wipe out U.K. conservatives
The Campaign Moment: A chaotic 96 hours inside Biden world
The Supreme Court granted Trump broad immunity. What now?
The Campaign Moment: Dems in panic mode after the debate
She's a U.S. citizen, he's undocumented: A love story.
How bullying shaped the surgeon general's fight against social media
Why Mexico City is worried about Day Zero
The fall of Alex Jones and his conspiracy empire